Investment
Features
FeesSafety
Academy
More
Pluang+

Compare H.M. Sampoerna Tbk. (HMSP) vs Indofarma Tbk. (INAF) Price & Performance

H.M. Sampoerna Tbk.Trade
Indofarma Tbk.Trade

Price performance (Past 24H)

Key statistics

H.M. Sampoerna Tbk. vs Indofarma Tbk. — how do they compare? H.M. Sampoerna Tbk. trades at Rp730 (market cap 86.08T, 6.17M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: H.M. Sampoerna Tbk. is far larger — about 220.4× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.

HMSPINAF
Market Cap
86.08T390.51B
Volume
6.17M
Lot
61.7K
Turnover
4.52B
Average Price
732.19
Value
4.52B
Indicative Equilibrium Price
730
Indicative Equilibrium Volume
3.68K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HMSP
View details
INAF
View details

About H.M. Sampoerna Tbk.

PT Hanjaya Mandala Sampoerna Tbk (the Company) was established in Indonesia on October 19, 1963 based on Notarial Deed No. 69 of Anwar Mahajudin, S.H.. The Company started its commercial operation since 1913 in Surabaya, as a home industry. In 1930, this home industry was officially organized under the name of NVBM Handel Maatschapij Sampoerna.

Read more on HMSP

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF